| Serial Number | 98044695 |
| Word Mark | TESCENDO |
| Filing Date | Thursday, June 15, 2023 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Tuesday, September 24, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Custom manufacturing of pharmaceuticals; providing technical information in the field of pharmaceutical manufacturing; manufacturing of cell therapy platforms for others |
| Goods and Services | Cells for medical or clinical use; pharmaceutical preparations and therapeutic agents for the treatment of cancer, infectious diseases, autoimmune and inflammatory conditions, and genetic diseases and non-genetic endocrine diseases, degenerative diseases, and aging disorders; therapeutic kits comprised of biological and pharmaceutical preparations for use in treatment and therapy for cancer, infectious diseases, autoimmune and inflammatory conditions, and genetic diseases and non-genetic endocrine diseases, degenerative diseases, and aging disorders; test kits for diagnostic preparations for medical purposes comprised of medical diagnostic reagents and assays for testing of body fluids and also containing a sample preparation device for medical diagnostic uses; T-cell receptors expressed on the cell for use in connection with diagnosing and treating cancer, infectious diseases, autoimmune and inflammatory conditions, and genetic diseases and non-genetic endocrine diseases, degenerative diseases, and aging disorders; diagnostic reagents for medical clinical use for treatment of cancer; cell culture kits for medical use primarily comprised of imaging and detection agents for diagnosing and monitoring cancer, and also containing a diagnostic apparatus for medical purposes used in medical laboratories for testing cancer cells; medical testing and treatment product kits primarily comprised of cells for diagnosing and treating cancer, infectious diseases, autoimmune and inflammatory conditions, and genetic diseases and non-genetic endocrine diseases, degenerative diseases, and aging disorders |
| Goods and Services | Reagents for scientific and research purposes, drug discovery research and scientific development, and biological and pharmaceutical reagents, for scientific and research purposes, for use in the manufacturing process of cell therapy platforms; diagnostic reagents for scientific clinical use for treatment of cancer |
| Goods and Services | Medical services; medical services, namely, cellular immunotherapy treatments; medical services, namely, human cancer treatment; providing medical information relating to immunotherapy; providing cancer therapy advice and consultancy |
| Goods and Services | Medical and scientific research services; medical laboratory services; providing information on medical and scientific research in the field of oncology; compiling and analyzing data for research purposes in the field of oncology; consulting in the field of medical and scientific research |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 19, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 19, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 19, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 19, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 19, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | The Board of Regents of the University of Texas System |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 14 - State Agency |
| Address | Austin, TX 78701 |
| Event Date | Event Description |
| Monday, June 19, 2023 | NEW APPLICATION ENTERED |
| Wednesday, July 19, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, January 31, 2024 | ASSIGNED TO EXAMINER |
| Friday, May 3, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, August 7, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 7, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, August 7, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, February 7, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 7, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 7, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, May 3, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Sunday, September 15, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Sunday, September 15, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Sunday, September 15, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Sunday, September 15, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, September 24, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |